Regeneron Pharmaceuticals
Patents, Design & Utilities
Last updated:
List of all Regeneron Pharmaceuticals patents 704 in total
| Status | Patent |
|---|---|
Application | Utility: METHODS OF TREATING CERVICAL CANCER BY ADMINISTERING A PD-1 INHIBITOR Filling date: 12 Sep 2025 Issue date: 30 Dec 2021 |
Grant | Utility: Compositions and methods for internalizing enzymes Filling date: 12 Sep 2025 Issue date: 28 Dec 2021 |
Grant | Utility: Histidine engineered light chain antibodies and genetically modified non-human animals for generating same Filling date: 12 Sep 2025 Issue date: 7 Dec 2021 |
Grant | Utility: Multispecific antigen-binding molecules and uses thereof Filling date: 12 Sep 2025 Issue date: 7 Dec 2021 |
Grant | Utility: Non-human animals expressing humanized C1Q complex Filling date: 12 Sep 2025 Issue date: 30 Nov 2021 |
Grant | Utility: Humanized C5 animals Filling date: 12 Sep 2025 Issue date: 23 Nov 2021 |
Grant | Utility: Anti-VEGF protein compositions and methods for producing the same Filling date: 12 Sep 2025 Issue date: 16 Nov 2021 |
Grant | Utility: Human antibodies to Fel d1 and methods of use thereof Filling date: 12 Sep 2025 Issue date: 16 Nov 2021 |
Grant | Utility: Readily isolated bispecific antibodies with native immunoglobulin format Filling date: 12 Sep 2025 Issue date: 9 Nov 2021 |
Grant | Utility: Anti-PSMA antibodies, bispecific antigen-binding molecules that bind PSMA and CD3, and uses thereof Filling date: 12 Sep 2025 Issue date: 26 Oct 2021 |
Application | Utility: MICE EXPRESSING A LIMITED IMMUNOGLOBULIN LIGHT CHAIN REPERTOIRE Filling date: 12 Sep 2025 Issue date: 14 Oct 2021 |
Application | Utility: NUCLEIC ACID CONSTRUCTS AND METHODS OF USE Filling date: 12 Sep 2025 Issue date: 14 Oct 2021 |
Application | Utility: Ultraviolet Monitoring of Chromatography Performance by Orthogonal Partial Least Squares Filling date: 12 Sep 2025 Issue date: 14 Oct 2021 |
Grant | Utility: Cas-ready mouse embryonic stem cells and mice and uses thereof Filling date: 12 Sep 2025 Issue date: 28 Sep 2021 |
Grant | Utility: Anti-Zika virus antibodies and methods of use Filling date: 12 Sep 2025 Issue date: 14 Sep 2021 |
Grant | Utility: Methods for reducing lipoprotein(a) levels by administering an inhibitor of proprotein convertase subtilisin kexin-9 (PCSK9) Filling date: 12 Sep 2025 Issue date: 14 Sep 2021 |
Grant | Utility: Humanized IL-4 and IL-4Ra animals Filling date: 12 Sep 2025 Issue date: 7 Sep 2021 |
Grant | Utility: Non-human animals that select for light chain variable regions that bind antigen Filling date: 12 Sep 2025 Issue date: 7 Sep 2021 |
Grant | Utility: Methods for producing aflibercept in chemically defined media having reduced aflibercept variants Filling date: 12 Sep 2025 Issue date: 31 Aug 2021 |
Grant | Utility: Humanized IL-6 and IL-6 receptor Filling date: 12 Sep 2025 Issue date: 31 Aug 2021 |
Grant | Utility: High concentration VEGF receptor fusion protein containing formulations Filling date: 12 Sep 2025 Issue date: 31 Aug 2021 |
Grant | Utility: Non-human animals having a humanized lymphocyte-activation gene 3 Filling date: 12 Sep 2025 Issue date: 31 Aug 2021 |
Grant | Utility: Methods of treating eye disorders with APLNR antagonists and VEGF inhibitors Filling date: 12 Sep 2025 Issue date: 31 Aug 2021 |
Grant | Utility: Anti-VEGF protein compositions and methods for producing the same Filling date: 12 Sep 2025 Issue date: 24 Aug 2021 |
Grant | Utility: Anti-VEGF protein compositions and methods for producing the same Filling date: 12 Sep 2025 Issue date: 24 Aug 2021 |
Grant | Utility: Cornulin (CRNN) variants and uses thereof Filling date: 12 Sep 2025 Issue date: 24 Aug 2021 |
Grant | Utility: Stabilized formulations containing anti-interleukin-6 receptor (IL-6R) antibodies Filling date: 12 Sep 2025 Issue date: 24 Aug 2021 |
Grant | Utility: VEGF antagonist formulations suitable for intravitreal administration Filling date: 12 Sep 2025 Issue date: 10 Aug 2021 |
Grant | Utility: Efficient selectivity of recombinant proteins Filling date: 12 Sep 2025 Issue date: 10 Aug 2021 |
Grant | Utility: Methods and formulations for treating vascular eye diseases using aflibercept and nesvacumab Filling date: 12 Sep 2025 Issue date: 27 Jul 2021 |
Grant | Utility: Anti-CD3 antibodies, bispecific antigen-binding molecules that bind CD3 and CD20, and uses thereof Filling date: 12 Sep 2025 Issue date: 27 Jul 2021 |
Application | Utility: METHODS OF TREATING SEVERE INSULIN RESISTANCE BY INTERFERING WITH GLUCAGON RECEPTOR SIGNALING Filling date: 12 Sep 2025 Issue date: 22 Jul 2021 |
Application | Utility: DEGLYCOSYLATION METHODS FOR ELECTROPHORESIS OF GLYCOSYLATED PROTEINS Filling date: 12 Sep 2025 Issue date: 22 Jul 2021 |
Application | Utility: HYDROPHOBIC INTERACTION CHROMATOGRAPHY FOR VIRAL CLEARANCE Filling date: 12 Sep 2025 Issue date: 22 Jul 2021 |
Application | Utility: Use of Amino Acids to Enhance Signal in Mass Spectral Analyses Filling date: 12 Sep 2025 Issue date: 22 Jul 2021 |
Grant | Utility: VEGF antagonist formulations suitable for intravitreal administration Filling date: 12 Sep 2025 Issue date: 20 Jul 2021 |
Grant | Utility: Production cell line enhancers Filling date: 12 Sep 2025 Issue date: 20 Jul 2021 |
Grant | Utility: Anti-TrkB monoclonal antibodies and methods of use Filling date: 12 Sep 2025 Issue date: 20 Jul 2021 |
Application | Utility: DEVICES AND METHODS FOR PRECISION DOSE DELIVERY Filling date: 12 Sep 2025 Issue date: 15 Jul 2021 |
Application | Utility: ASSEMBLY LINE WITH INTEGRATED ELECTRONIC VISUAL INSPECTION Filling date: 12 Sep 2025 Issue date: 15 Jul 2021 |
Application | Utility: COMBINATION OF ANTI-PD-1 ANTIBODIES AND BISPECIFIC ANTI-CD20/ANTI-CD3 ANTIBODIES TO TREAT CANCER Filling date: 12 Sep 2025 Issue date: 15 Jul 2021 |
Application | Utility: ANTI-VEGF PROTEIN COMPOSITIONS AND METHODS FOR PRODUCING THE SAME Filling date: 12 Sep 2025 Issue date: 15 Jul 2021 |
Application | Utility: ANTI-VEGF PROTEIN COMPOSITIONS AND METHODS FOR PRODUCING THE SAME Filling date: 12 Sep 2025 Issue date: 15 Jul 2021 |
Grant | Utility: Stabilized formulations containing anti-interleukin-4 receptor (IL-4R) antibodies Filling date: 12 Sep 2025 Issue date: 13 Jul 2021 |
Application | Utility: COMMON LIGHT CHAIN MOUSE Filling date: 12 Sep 2025 Issue date: 8 Jul 2021 |
Application | Utility: USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERS Filling date: 12 Sep 2025 Issue date: 8 Jul 2021 |
Application | Utility: Stabilized Formulations Containing Anti-CD20 x Anti-CD3 Bispecific Antibodies Filling date: 12 Sep 2025 Issue date: 8 Jul 2021 |
Application | Utility: Methods of Treating Multiple Myeloma with Bispecific Anti-BCMA x Anti-CD3 Antibodies Filling date: 12 Sep 2025 Issue date: 8 Jul 2021 |
Application | Utility: ANTI-VEGF PROTEIN COMPOSITIONS AND METHODS FOR PRODUCING THE SAME Filling date: 12 Sep 2025 Issue date: 8 Jul 2021 |
Application | Utility: METHODS FOR PRODUCING AFLIBERCEPT IN CHEMICALLY DEFINED MEDIA HAVING REDUCED AFLIBERCEPT VARIANTS Filling date: 12 Sep 2025 Issue date: 8 Jul 2021 |
Showing 100 to 150 of 704 patents.